Shang-Gin Wu

发表

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

J. Shih, Shang-Gin Wu, 2018, Molecular Cancer.

IGFBP7 Drives Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition in Lung Cancer

Yih-Leong Chang, J. Shih, Chia-Lang Hsu, 2019, Cancers.

Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation.

J. Shih, Pan‐Chyr Yang, Chong-Jen Yu, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Frequent EGFR mutations in malignant pleural effusion of lung adenocarcinoma

Yih-Leong Chang, J. Shih, Chih-Hsin Yang, 2008 .

Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection.

Pan‐Chyr Yang, Hsin-Yun Sun, Shang-Gin Wu, 2009, Journal of hospital medicine.

Clinical outcomes of Atezolizumab Therapy for Previously-Treated Advanced-Stage Non-Small Cell Lung Cancer: A Real-World Study in Taiwan

J. Shih, T. Hsia, J. Hung, 2022, Journal of Cancer.

Livestock-associated Staphylococcus aureus in Childcare Worker

Shang-Gin Wu, Shang-Ju Wu, Tzu-Hsiu Tsai, 2019 .

Acute Cytomegalovirus Pneumonitis in Patient with Lymphomatoid Granulomatosis

Shang-Gin Wu, Shang-Ju Wu, Tzu-Hsiu Tsai, 2011, Emerging infectious diseases.

Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non–Small-Cell Lung Cancer

J. Shih, Pan‐Chyr Yang, J. Yang, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Successful weaning after plasma exchange for polyneuropathy related to POEMS syndrome

Pan‐Chyr Yang, Shang-Gin Wu, P. Kuo, 2009, Journal of clinical apheresis.

MicroRNA in Lung Cancer Metastasis

J. Shih, Yi-nan Liu, Shang-Gin Wu, 2019, Cancers.

Survival of lung adenocarcinoma patients with malignant pleural effusion

J. Shih, Pan‐Chyr Yang, Chong-Jen Yu, 2012, European Respiratory Journal.

A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population.

J. Shih, C. Gow, Shang-Gin Wu, 2017, Lung cancer.

Lung Cancer with Epidermal Growth Factor Receptor Exon 20 Mutations Is Associated with Poor Gefitinib Treatment Response

Yih-Leong Chang, J. Shih, Pan‐Chyr Yang, 2008, Clinical Cancer Research.

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

J. Shih, Shang-Gin Wu, 2018, Molecular Cancer.

The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition

Yih-Leong Chang, J. Shih, Pan‐Chyr Yang, 2016, Scientific Reports.

EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway

J. Shih, Pan‐Chyr Yang, Shang-Gin Wu, 2015, Scientific Reports.

High throughput sequencing of T-cell receptor repertoire using dry blood spots

Hongna Liu, Shang-Gin Wu, Jian Han, 2019, Journal of Translational Medicine.

Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: identification of a rare CD74-NRG1 translocation case

Yih-Leong Chang, J. Shih, C. Gow, 2014, Medical Oncology.

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Yih-Leong Chang, J. Shih, Pan‐Chyr Yang, 2016, Oncotarget.

miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway

J. Shih, Yi-nan Liu, C. Gow, 2020, Molecular therapy. Nucleic acids.

Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors

Yih-Leong Chang, J. Shih, Pan‐Chyr Yang, 2017, ERJ Open Research.

Brain Metastasis of Patients with Lung Adenocarcinoma: Epidermal Growth Factor Receptor Mutations and Response to Whole-Brain Radiation Therapy

J. Shih, Shang-Gin Wu, 2014 .

Effusion Immunocytochemistry as an Alternative Approach for the Selection of First-Line Targeted Therapy in Advanced Lung Adenocarcinoma

Yih-Leong Chang, J. Shih, Chen‐Tu Wu, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis

Yih-Leong Chang, J. Shih, Yung‐Chie Lee, 2012, European Respiratory Journal.

Clinical Outcomes in Non–Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR

J. Shih, Pan‐Chyr Yang, J. Yang, 2012, Clinical Cancer Research.

Frequent EGFR Mutations in NSCLC Presenting with Miliary Intrapulmonary Carcinomatosis

Yih-Leong Chang, J. Shih, Yeun-Chung Chang, 2012 .

Including Total EGFR Staining in Scoring Improves EGFR Mutations Detection by Mutation-Specific Antibodies and EGFR TKIs Response Prediction

Yih-Leong Chang, J. Shih, Chen‐Tu Wu, 2011, PloS one.

Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations.

Jih-Hsiang Lee, Yih-Leong Chang, J. Shih, 2011, Lung cancer.

Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern.

Meng-Feng Tsai, Chong-Jen Yu, Jin-Yuan Shih, 2008, The oncologist.

Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor.

J. Shih, Sung-Liang Yu, Pan‐Chyr Yang, 2011, American journal of respiratory and critical care medicine.

Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations.

Yeun-Chung Chang, Jin-Yuan Shih, Yih-Leong Chang, 2011, Lung cancer.

First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer.

J. Shih, Yeun-Chung Chang, Y. Chiu, 2008, American journal of respiratory and critical care medicine.

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation

J. Shih, J. Yang, Chong-Jen Yu, 2020, Therapeutic advances in medical oncology.

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor‐sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non–Small‐cell Lung Cancer

J. Shih, J. Yang, Yi-nan Liu, 2017, Clinical lung cancer.

EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR

Yih-Leong Chang, J. Shih, Pan‐Chyr Yang, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Efficacy of Pemetrexed‐Based Chemotherapy in Patients with ROS1 Fusion–Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations

Yih-Leong Chang, J. Shih, Pan‐Chyr Yang, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion.

J. Shih, J. Yang, Chong-Jen Yu, 2015, Lung cancer.

Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations

Yih-Leong Chang, J. Shih, Pan‐Chyr Yang, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.

J. Shih, Chia-Lang Hsu, Yi-nan Liu, 2020, Cancer biomarkers : section A of Disease markers.

Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.

Yih-Leong Chang, J. Shih, Sung-Liang Yu, 2017, Cancer letters.

Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan

J. Shih, Sung-Liang Yu, Chong-Jen Yu, 2020, JTO clinical and research reports.

Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer.

J. Shih, Yi-nan Liu, Chong-Jen Yu, 2020, Lung cancer.

Association of BIM Deletion Polymorphism With Intrinsic Resistance to EGFR Tyrosine Kinase Inhibitors in Patients With Lung Adenocarcinoma.

J. Shih, Pan‐Chyr Yang, Yi-nan Liu, 2016, JAMA oncology.

Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion

J. Shih, J. Yang, Yi-nan Liu, 2018, Genes, chromosomes & cancer.

Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation.

J. Shih, Shang-Gin Wu, Chao-Chi Ho, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pericardial pigtail knotting.

J. Shih, Shang-Gin Wu, 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan

J. Shih, T. Hsia, G. Chang, 2020, Frontiers in Oncology.

Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study

J. Shih, Yi-nan Liu, C. Gow, 2023, Frontiers in Oncology.

Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas

J. Shih, J. Yang, A. Cheng, 2013, Journal of Neuro-Oncology.

Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer

Yih-Leong Chang, J. Shih, Yi-nan Liu, 2019, International journal of cancer.

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

J. Shih, Hsuan-Yu Chen, Sung-Liang Yu, 2015, Oncotarget.